Efficacy of Antioxidant Supplementation in Reducing Primary Cancer Incidence and Mortality: Systematic Review and Meta-analysis
- Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA? Willem Remme; Jaap Deckers; Kim Fox; Roberto Ferrari; Michel Bertrand; Maarten Simoons // Cardiovascular Drugs & Therapy;Apr2009, Vol. 23 Issue 2, p161
Abstract AimsÂ Â We determined whether blood pressure (BP) lowering by perindopril was related to its benefit in the EUROPA study. Methods and resultsÂ Â Twelve thousand two hundred eighteen patients with documented coronary artery disease received perindopril 8Â mg once daily or...
- Attenuation of Post-ischemia Reperfusion Injury by Thaliporphine and Morphine in Rat Hearts. Wei-Luen Chang; Shoei-Sheng Lee; Ming-Jai Su // Journal of Biomedical Science;Jul2005, Vol. 12 Issue 4, p611
Pretreatment with thaliporphine before ischemia affords cardioprotective effects against reperfusion injury via antioxidant activity. This study evaluated whether thaliporphine administered at a certain period after myocardial ischemia conferred the same cardioprotection and assessed its...
- Relationship between total antioxidant capacity and the severity of coronary artery disease. Aydın, Murat; Selcoki, Yusuf; Nazlı, Yunus; Çolak, Necmettin; Serkan Yalçın, Kadir; Canbal, Metin; Demirçelik, Bora; Yiğitoğlu, Ramazan; Eryonucu, Beyhan // Journal of Clinical & Experimental Investigations / Klinik ve De;2012, Vol. 3 Issue 1, p22
Objectives: It was known that oxidative/antioxidative balance shifted to oxidative side in patients with coronary artery disease. The aim of this study is to evaluate the relationship between coronary artery disease and total antioxidant status, oxidative stress index. Materials and methods: The...
- Intercoronary communication between the circumflex and right coronary arteries: distinct from coronary collaterals. Atak, R.; Guray, U.; Akin, Y. // Heart;Jul2002, Vol. 88 Issue 1, p29
Presents a case of intercoronary artery continuity with atypical chest pain. Findings of the coronary angiography; Types of intercoronary artery continuity; Selective injection of the right coronary artery.
- Obstruction of Coronary Artery--1912. Herrick, James B. // Annals of Internal Medicine;Dec76, Vol. 85 Issue 6, p803
Presents an excerpt from the article 'Clinical Features of Sudden Obstruction of the Coronary Arteries,' published in the 1912 issue of the 'Journal of American Medical Association.'
- Newly developed lesions in right coronary artery during PCI. Güler, Ahmet; Güler, Yeliz; Kırma, Cevat // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Aug2014, Vol. 14 Issue 5, p484
A quiz concerning a case study of a 57-year-old male who was diagnosed with newly developed lesions in right coronary artery during percutaneous coronary intervention (PCI).
- VIDEO COMMENTARY ON "IMAGING THE CORONARY SINUS". Irpachi, Kalpana; Kapoor, Poonam Malhotra; Narula, Jitin; Sahu, Manoj // Annals of Cardiac Anaesthesia;Apr-Jun2015, Vol. 18 Issue 2, p216
A video commentary on the article "Imaging the Coronary Sinus" is presented.
- Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Karuppasamy, Partheeban; Chaubey, Sanjay; Dew, Tracy; Musto, Rebecca; Sherwood, Roy; Desai, Jatin; John, Lindsay; Shah, Ajay; Marber, Michael; Kunst, Gudrun // Basic Research in Cardiology;Jul2011, Vol. 106 Issue 4, p511
Perioperative myocardial ischemia contributes to postoperative morbidity and mortality. Remote intermittent ischemia (RI) has been shown to benefit patients undergoing coronary artery bypass graft (CABG) surgery by decreasing postoperative cardiac troponin levels. In addition, there is evidence...
- Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. Castro, R. R. T.; Porphirio, G.; Serra, S. M.; Nóbrega, A. C. L. // Heart;Oct2004, Vol. 90 Issue 10, p1119
Objective: To determine the acute effects of pyridostigmine bromide, a reversible cholinesterase inhibitor, during exercise in patients with coronary artery disease. Design: Double blind, randomised, placebo controlled, crossover study. Setting: Outpatients evaluated in an exercise test...